Your AI-Trained Oncology Knowledge Connection!

Louise Emmett

Articles by Louise Emmett

TPS 24 Phase Ib Dose-Finding Study of [177Lu]Lu-NeoB + Ribociclib + Fulvestrant in Patients With ER+/HER2− Advanced Breast Cancer With GRPR Expression With Early Relapse FromAdjuvant Endocrine Therapy or Progression on ET + CDK4/6i for ABC

ByDebasish Tripathy,Dejan Juric,Sonia Pernas,Francois Clement Bidard,Kevin Perraud,Louise Emmett,Ana Sofia Ferreira

June 22nd 2025

TPS 25 Phase 1/2 Study of the Novel Radioligand Therapy [177Lu]Lu-NeoB Plus Capecitabine in Patients With ER+/HER2− Advanced Breast Cancer (ABC) With GRPR Expression After Progression on Prior Endocrine Therapy Plus a CDK4/6 Inhibitor for ABC

ByMario Campone,Louise Emmett,Dejan Juric,Debasish Tripathy,Sonia Pernas,Monica Zuradelli,Kevin Perraud,Aleix Prat

June 21st 2025

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Imlunestrant in ER+/HER2– ESR1+ Breast Cancer

Understanding “Paradigm-Changing” Events in Small Cell Lung Cancer Care

Atebimetinib Plus SOC Chemo Improves Survival/Safety in 1L PDAC

Five-Year Cancer Survival Rates Lower Among Rural Cancer Populations

Boston’s Best Did Not “Leave the Cannoli” in Battle of Lymphoma Top Trials

© 2025 MJH Life Sciences^®

All rights reserved.